Page 32 - Read Online

Mudra et al. J Cancer Metastasis Treat 2019;5:27 I http://dx.doi.org/10.20517/2394-4722.2019.09 Page 7 of 9

REFERENCES
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69:7-34.
2. McGranahan T, Nagpal S. A neuro-oncologist’s perspective on management of brain metastases in patients with EGFR mutant non-small
cell lung cancer. Curr Treat Options Oncol 2017;18:22.
3. Waqar SN, Samson PP, Robinson CG, Bradley J, Devarakonda S, et al. Non-small-cell lung cancer with brain metastasis at presentation.
Clin Lung Cancer 2018;19:e373-e9.
4. Quan AL, Videtic GM, Suh JH. Brain metastases in small cell lung cancer. Oncology (Williston Park) 2004;18:961-72; discussion 74, 79-
80, 87.
5. Bui N, Woodward B, Johnson A, Husain H. Novel treatment strategies for brain metastases in non-small-cell lung cancer. Curr Treat
Options Oncol 2016;17:25.
6. Wang YY, Wang YS, Liu T, Yang K, Yang GQ, et al. Efficacy study of CyberKnife stereotactic radiosurgery combined with CIK cell
immunotherapy for advanced refractory lung cancer. Exp Ther Med 2013;5:453-6.
7. Thapa B, Lauko A, Desai K, Venur VA, Ahluwalia MS. Novel systemic treatments for brain metastases from lung cancer. Curr Treat
Options Neurol 2018;20:48.
8. NCCN Clinical Practice Guidelines in Oncology. Non-Small Cell Lung Cancer, Version 2.2019. NCCN Clinical Practice Guidelines in
Oncology (NCCN Guidelines); 2018.
9. Sperduto PW, Yang TJ, Beal K, Pan H, Brown PD, et al. Estimating survival in patients with lung cancer and brain metastases: an update
of the graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA). JAMA Oncol 2017;3:827-31.
10. Bergsma DP, Salama JK, Singh DP, Chmura SJ, Milano MT. Radiotherapy for oligometastatic lung cancer. Front Oncol 2017;7:210.
11. Aly Z, Peereboom DM. Combination of radiotherapy and targeted agents in brain metastasis: an update. Curr Treat Options Neurol
2016;18:32.
12. Linskey ME, Andrews DW, Asher AL, Burri SH, Kondziolka D, et al. The role of stereotactic radiosurgery in the management of patients
with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010;96:45-68.
13. Fuentes R, Osorio D, Exposito Hernandez J, Simancas-Racines D, Martinez-Zapata MJ, et al. Surgery versus stereotactic radiotherapy for
people with single or solitary brain metastasis. Cochrane Database Syst Rev 2018;8:Cd012086.
14. O’Neill BP, Iturria NJ, Link MJ, Pollock BE, Ballman KV, et al. A comparison of surgical resection and stereotactic radiosurgery in the
treatment of solitary brain metastases. Int J Radiat Oncol Biol Phys 2003;55:1169-76.
15. Routman DM, Yan E, Vora S, Peterson J, Mahajan A, et al. Preoperative stereotactic radiosurgery for brain metastases. Front Neurol
2018;9:959.
16. Asher AL, Burri SH, Wiggins WF, Kelly RP, Boltes MO, et al. A new treatment paradigm: neoadjuvant radiosurgery before surgical
resection of brain metastases with analysis of local tumor recurrence. Int J Radiat Oncol Biol Phys 2014;88:899-906.
17. Patel KR, Burri SH, Asher AL, Crocker IR, Fraser RW, et al. Comparing preoperative with postoperative stereotactic radiosurgery for
resectable brain metastases: A multi-institutional analysis. J Neurooncol 2017;131:611-8.
18. Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, et al. Summary report on the graded prognostic assessment: an accurate and facile
diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 2012;30:419-25.
19. Halasz LM, Uno H, Hughes M, D’Amico T, Dexter EU, et al. Comparative effectiveness of stereotactic radiosurgery versus whole-brain
radiation therapy for patients with brain metastases from breast or non-small cell lung cancer. Cancer 2016;122:2091-100.
20. Yamamoto M, Serizawa T, Shuto T, Akabane A, Higuchi Y, et al. Stereotactic radiosurgery for patients with multiple brain metastases
(JLGK0901): a multi-institutional prospective observational study. Lancet Oncol 2014;15:387-95.
21. Sneed PK, Mendez J, Vemer-van den Hoek JG, Seymour ZA, Ma L, et al. Adverse radiation effect after stereotactic radiosurgery for brain
metastases: incidence, time course, and risk factors. J Neurosurg 2015;123:373-86.
22. Chin LS, Lazio BE, Biggins T, Amin P. Acute complications following Gamma Knife radiosurgery are rare. Surg Neurol 2000;53:498-
502; discussion 502.
23. Miller JA, Bennett EE, Xiao R, Kotecha R, Chao ST, et al. Association between radiation necrosis and tumor biology after stereotactic
radiosurgery for brain metastasis. Int J Radiat Oncol Biol Phys 2016;96:1060-9.
24. Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary
brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 2000;47:291-8.
25. Yamamoto M, Serizawa T, Higuchi Y, Sato Y, Kawagishi J, et al. A multi-institutional prospective observational study of stereotactic
radiosurgery for patients with multiple brain metastases (JLGK0901 Study Update): Irradiation-related complications and long-term
maintenance of mini-mental state examination scores. Int J Radiat Oncol Biol Phys 2017;99:31-40.
26. Minniti G, Scaringi C, Paolini S, Lanzetta G, Romano A, et al. Single-fraction versus multifraction (3 x 9 Gy) stereotactic radiosurgery
for large (>2 cm) brain metastases: a comparative analysis of local control and risk of radiation-induced brain necrosis. Int J Radiat Oncol
Biol Phys 2016;95:1142-8.
27. Masucci GL. Hypofractionated radiation therapy for large brain metastases. Front Oncol 2018;8:379.
28. Margolin K, Ernstoff MS, Hamid O, Lawrence D, McDermott D, et al. Ipilimumab in patients with melanoma and brain metastases: an
open-label, phase 2 trial. Lancet Oncol 2012;13:459-65.
29. El Rassy E, Botticella A, Kattan J, Le Pechoux C, Besse B, et al. Non-small cell lung cancer brain metastases and the immune system:
from brain metastases development to treatment. Cancer Treat Rev 2018;68:69-79.
30. Berghoff AS, Fuchs E, Ricken G, Mlecnik B, Bindea G, et al. Density of tumor-infiltrating lymphocytes correlates with extent of brain
edema and overall survival time in patients with brain metastases. Oncoimmunology 2015;5:e1057388.
31. Frey B, Rubner Y, Kulzer L, Werthmoller N, Weiss EM, et al. Antitumor immune responses induced by ionizing irradiation and further
immune stimulation. Cancer Immunol Immunother 2014;63:29-36.